1. Home
  2. VYGR vs TRAK Comparison

VYGR vs TRAK Comparison

Compare VYGR & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.79

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

TRAK

ReposiTrak Inc.

HOLD

Current Price

$8.37

Market Cap

212.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
TRAK
Founded
2013
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
194.0M
212.5M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
VYGR
TRAK
Price
$3.79
$8.37
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$17.00
N/A
AVG Volume (30 Days)
527.4K
75.6K
Earning Date
01-01-0001
06-08-2026
Dividend Yield
N/A
0.95%
EPS Growth
N/A
20.69
EPS
N/A
0.18
Revenue
$10,135,000.00
$21,007,076.00
Revenue This Year
N/A
$8.29
Revenue Next Year
$71.77
$24.17
P/E Ratio
N/A
$46.56
Revenue Growth
N/A
4.84
52 Week Low
$2.65
$8.38
52 Week High
$5.55
$23.72

Technical Indicators

Market Signals
Indicator
VYGR
TRAK
Relative Strength Index (RSI) 47.48 19.08
Support Level $2.79 N/A
Resistance Level $3.73 $10.75
Average True Range (ATR) 0.21 0.42
MACD 0.00 -0.15
Stochastic Oscillator 54.65 0.00

Price Performance

Historical Comparison
VYGR
TRAK

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.

Share on Social Networks: